A rise in cytosolic Ca 2+ concentration is used as a key activation signal in virtually all animal cells, where it triggers a range of responses, including neurotransmitter release, muscle contraction, and cell growth and proliferation [1, 2] . A major route for Ca 2+ influx is through store-operated Ca 2+ channels. One important intracellular target for Ca 2+ entry through store-operated channels is the mitochondrion, which increases aerobic metabolism and ATP production after Ca 2+ uptake. Here, we reveal a novel feedback pathway whereby pyruvic acid, a critical rate-limiting substrate for mitochondrial respiration, increases store-operated entry by reducing inactivation of the channels. Importantly, the effects of pyruvic acid are manifest at physiologically relevant concentrations and membrane potentials. The reduction in the inactivation of calcium release-activated calcium (CRAC) channels by pyruvate is highly specific in that it is not mimicked by other intermediary metabolic acids, does not require its metabolism, is independent of its Ca 2+ buffering action, and does not involve mitochondrial Ca 2+ uptake or ATP production. These results reveal a new and direct link between intermediary metabolism and ion-channel gating and identify pyruvate as a potential signaling messenger linking energy demand to calcium-channel function.
Summary
A rise in cytosolic Ca 2+ concentration is used as a key activation signal in virtually all animal cells, where it triggers a range of responses, including neurotransmitter release, muscle contraction, and cell growth and proliferation [1, 2] . A major route for Ca 2+ influx is through store-operated Ca 2+ channels. One important intracellular target for Ca 2+ entry through store-operated channels is the mitochondrion, which increases aerobic metabolism and ATP production after Ca 2+ uptake. Here, we reveal a novel feedback pathway whereby pyruvic acid, a critical rate-limiting substrate for mitochondrial respiration, increases store-operated entry by reducing inactivation of the channels. Importantly, the effects of pyruvic acid are manifest at physiologically relevant concentrations and membrane potentials. The reduction in the inactivation of calcium release-activated calcium (CRAC) channels by pyruvate is highly specific in that it is not mimicked by other intermediary metabolic acids, does not require its metabolism, is independent of its Ca 2+ buffering action, and does not involve mitochondrial Ca 2+ uptake or ATP production. These results reveal a new and direct link between intermediary metabolism and ion-channel gating and identify pyruvate as a potential signaling messenger linking energy demand to calcium-channel function.
Results and Discussion

Ca
2+ entry through store-operated calcium releaseactivated calcium (CRAC) channels is rapidly taken up by mitochondria [3, 4] , stimulating ATP production through activation of key Ca 2+ -dependent rate-limiting enzymes of the Krebs cycle [5, 6] . In turn, by buffering cytoplasmic Ca 2+ , mitochondria reduce Ca 2+ -dependent inactivation of CRAC channels and thus maintain channel activity [7, 8] . Not all of the effects of mitochondria on CRAC channels can be explained by Ca 2+ buffering, however [9] , and it is possible that mitochondriallyderived signals might help control this ubiquitous Ca 2+ -entry pathway [4] , as has been suggested for insulin secretion and Na + -channel activity [10, 11] . Here, we have tested this idea by examining the effects of numerous intermediary metabolites on CRAC-channel activity.
CRAC channels exhibit Ca
2+
-dependent rapid inactivation, which develops within milliseconds and is triggered by the build-up of a microdomain of elevated Ca 2+ beneath each open channel [12] [13] [14] . Rapid inactivation is a general feature of CRAC channels expressed in different cell types [15] . Figure 1 compares the rate and extent of rapid inactivation in the presence of different Ca 2+ chelators. After whole-cell dialysis of an RBL-1 cell with a pipette solution containing a strong buffer (10 mM ethyleneglycol-bis(b-aminoethyl)-N,N,N 0 ,N 0 -tetraacetic acid [EGTA] ) and the sarcoplasmic or endoplasmic reticulum Ca 2+ -ATPase pump blocker thapsigargin (2 mM) to empty stores, I CRAC developed slowly ( Figure 1A ). The characteristic current-voltage (I-V) relationship, taken at steady state, is shown in Figure 1B . Upon stepping to 2120mV (from a holding potential of 0mV), I CRAC initially increased but then declined substantially during the pulse ( Figure 1C ), revealing rapid inactivation. Inactivation was a double-exponential process, with time constants of w10 and w100 milliseconds [13, 14] . Inactivation was much less pronounced at 240mV ( Figure 1C ), where the driving force for Ca 2+ influx through the channels is reduced. Aggregate data over the voltage range of 240mV to 2120mV is shown in Figure 1J and the kinetics of inactivation at 2120mV is shown in Figure 1K . After dialysis with the faster Ca 2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N 0 ,N 0 -tetraacetic acid (BAPTA), I CRAC developed at a similar rate and extent to that of EGTA ( Figures 1D and 1E ), but rapid inactivation was considerably less (Figures 1F and 1J ; p < 0.01 for each point between 260mV and 2120mV). Inactivation kinetics were similar between BAPTA and EGTA ( Figure 1K ). Rapid inactivation in a mixture of EGTA and BAPTA (5 mM each; Figures 1G-1I ) lay between 10 mM EGTA and 10 mM BAPTA ( Figure 1J ).
To test whether metabolic signals regulated CRAC channels, we compared rapid inactivation in control cells (dialyzed cells with 5 mM EGTA and 2mM thapsigargin) with cells dialyzed with 5 mM EGTA, 2mM thapsigargin, and 5 mM of different intermediary metabolites. Inclusion of pyruvic acid had quite significant effects on CRAC-channel activity. Although the whole-cell current developed similarly under both conditions ( Figure 2A ) and with broadly similar I-V curves ( Figure 2B ), pyruvate dramatically reduced the extent of rapid inactivation ( Figure 2C ), over a range of voltages ( Figure 2D ; p < 0.01 for each voltage). The time constants of rapid inactivation were unaffected by pyruvate (Table S1 in the Supplemental Data available online).
The concentration of pyruvic acid in nonstimulated cells is w0.5 mM [16] , but it can double upon stimulation [16] . Hence pyruvate concentrations in the low millimolar range are likely to occur physiologically. To see whether these concentrations impacted rapid inactivation, we included different concentrations of pyruvate (0.1-5 mM) in the pipette solution and measured the extent of rapid inactivation at 2120mV ( Figure 2E ). The relationship could be fitted with a Hill-type equation, yielding a half-maximal pipette concentration (EC 50 ) of w1.6 mM. The effects of pyruvic acid were discernible as soon as I CRAC started to develop, which was generally within 50-100 s of the onset of whole-cell recording. At these times, pyruvic acid would not have equilibrated between the patch pipette and the cytosol, and the latter concentration would be considerably lower than that in the pipette. We estimated the rate of diffusion of pyruvic acid into the cell [17] (Figure 2F ; calculated for a pipette concentration of 5 mM). After 50-100 s, cytoplasmic pyruvic acid would be w1 mM, well within the physiological range. This estimation assumes that pyruvic acid is neither metabolized nor removed from the cell but simply equilibrates between the cytosolic compartment and the patch pipette. Because pyruvic acid is extensively metabolized, the simulation overestimates the rise of its intracellular concentration, and hence the effects probably occur at even lower concentrations.
We tested whether the effects of pyruvic acid could be explained by mitochondrial Ca 2+ buffering. However, dialysis with ruthenium red, an inhibitor of the mitochondrial Ca
-uptake channel and which suppresses mitochondrial buffering in RBl-1 cells [8] , failed to prevent the reduction in rapid inactivation evoked by pyruvate ( Figure 3A) .
To see whether other intermediary metabolites could substitute for pyruvate, we tested a range of dicarboxylic and tricarboxylic acids generated from the Krebs cycle ( Figure 3B ). Dialysis with 5 mM succinic acid, citric acid, oxaloacetic acid, or a-ketoglutaric acid were all much less effective ( Figure 3B ). Two main intracellular pathways for pyruvate metabolism are its conversion to acetyl coenzyme A, which enters the Krebs cycle, and to phosphoenolpyruvate, which is metabolized to oxaloacetic acid. Because a variety of Krebs-cycle intermediates and oxaloacetate failed to affect rapid inactivation, pyruvate metabolism by these major pathways is not necessary for the effects reported here.
Because free ATP can buffer cytoplasmic Ca 2+ , we considered that the effects of pyruvate were mediated through mitochondrial ATP generation. However, inhibition of the mitochondrial F1-F0ATPsynthase with oligomycin failed to alter the effects of pyruvate on rapid inactivation ( Figure 3C ), and the inactivation in pyruvate and oligomycin was similar to that seen in pyruvate. Moreover, because the vast majority of intracellular ATP is in the form of Mg-ATP, we increased Mg-ATP in the standard pipette solution to 10 mM (free Mg 2+ , w0.95 mM; free ATP, w270 mM). However, rapid inactivation was still prominent and was significantly less than that seen in the presence of pyruvic acid ( Figure 3D ; p < 0.01). Free ATP is normally kept at very low levels in healthy cells, with the vast majority of ATP being bound to Mg 2+ . However, free ATP in the millimolar range is sometimes used experimentally as a mobile Ca 2+ buffer, so we designed experiments to see whether high levels of free ATP could affect rapid inactivation of CRAC channels. Such experiments are complicated because of the generation of a nonselective cation current that is activated by low levels of Mg 2+ /Mg-ATP and is likely mediated by Ca 2+ -, Mg 2+ -, and Cs + -permeable TRPM7 channels [18, 19] . To reduce TRPM7 activation, we used a pipette solution containing 2 mM Mg-ATP along with 5 mM Na ATP (free ATP was calculated to be 3.8 mM and free Mg 2+ was 30 mM). Under these conditions, development of the TRPM7 current was slightly delayed, so I CRAC initially activated in relative isolation. Figure 3E plots the development of inward current (black circles, measured at 280mV) and outward current (white circles, measured at +80mV) after whole-cell dialysis with 5 mM EGTA, 5 mM Na-ATP, and 2 mM Mg-ATP. By 200 s, a time when I CRAC had fully developed, no detectable outward current was present, indicating little activation of TRPM7. Within 200 s, the extent of rapid inactivation was considerably more with 5 mM Na-ATP and 2 mM Mg-ATP than with pyruvate (57.0 6 1.55 for ATP versus 45 6 2.8% for pyruvate ; p < 0.01), demonstrating that the effects of pyruvate were not mediated by an increase in free ATP. After w220 s, a clear outward current developed, and this was accompanied by a small rise in inward current ( Figure 3E ). The I-V relationship ( Figure 3F ) revealed the prominent outward current at potentials positive to +50mV, characteristic of TRPM7 channels [18] . Importantly, hyperpolarizing steps to 2120mV at these later time points revealed less rapid inactivation of the whole-cell current ( Figure 3G , which compares rapid inactivation before and after the development of TRPM7, labeled ''a'' and ''b'' in Figure 3E ). We attribute this difference to the contaminating presence of the noninactivating TRPM7 current, which would mask the true inactivation of I CRAC . In a previous study, mitochondrially-derived ATP was claimed to act as a local Ca 2+ buffer [20] , preventing the slow inactivation of CRAC channels that develops over tens of seconds. In those experiments, Jurkat T cells were dialyzed with up to 10 mM Na-ATP in the presence of 10 mM EGTA, and no precautions were taken to eliminate TRPM7. Hence those recordings were likely severely contaminated by the development of TRPM7, masking the inactivation of CRAC channels [20] . Furthermore, interpretation of those authors' findings is complicated by the fact that the extent of inactivation they reported was very different between 10 mM Mg-ATP and 2 mM Na-ATP [20] , even though free ATP was similar in both cases (w1 and 1.3 mM). Hence it is difficult to see how these effects could actually be mediated by free ATP. Indeed, we see no difference in the extent of rapid inactivation between 5 mM Na + -ATP and 2 mM Mg-ATP (56.3 6 1.6%) and 10 mM Mg-ATP (57.2% 6 2.1), where free ATP differs by more than 10-fold (w3.8 and 0.27 mM, respectively).
Some intermediary metabolic acids like citric acid bind Ca 2+ and thus function as intracellular Ca 2+ buffers. Two arguments suggest that the effects of pyruvate are not through a Ca 2+ -buffering action. First, the affinity of pyruvate for Ca 2+ is low (K D of w12 mM), orders of magnitude below the range of cytosolic Ca 2+ rises in most cells. Second, we calculated the additional exogenous Ca 2+ -binding ratio (k B ), which reflects the buffering capacity of each ligand [21] , for each metabolic acid. The k B of the standard pipette solution is dominated by the 5 mM EGTA present, with small contributions from glutamic acid and free ATP (from Mg-ATP). The k B from each metabolic acid on top of this background is plotted against the extent of rapid inactivation in Figure 4A . Citrate has a 50-fold greater Ca 2+ -binding ratio than does pyruvate, yet it is much less effective in reducing rapid inactivation. Similarly, increasing free ATP adds more to the total k B than does 5 mM pyruvate, yet it is less effective in reducing inactivation. Hence the effect of pyruvate on rapid inactivation does not correlate with cytoplasmic Ca 2+ buffering. We considered the possibility that pyruvate evoked a noninactivating current, developing in parallel with I CRAC . However, dialysis with up to 10 mM pyruvate failed to activate a detectable current ( Figure 4B ; aggregate data in Figure 4C) . Moreover, the amplitude of I CRAC in 5 mM EGTA (22.21 6 0.17 pA/pF at 280mV) was similar to that seen in cells dialyzed with 5 mM EGTA and pyruvate (22.30 6 0.24 pA/pF; p > 0.2). Hence the effects of pyruvate cannot be explained by the generation of a non-store-operated current that develops in parallel with I CRAC .
Collectively, we have found that pyruvate reduces the rapid inactivation of CRAC channels and it does so without buffering cytosolic Ca 2+ . Because rapid inactivation is mediated at the channel itself [13, 22] , it is likely that pyruvate interferes with Ca 2+ by either competing at a binding site on the channel or by modifying the efficacy of Ca 2+ to mediate inactivation. We tested the specificity of the pyruvate effect on rapid inactivation by using divalent-free external solution, in which Na + replaces Ca 2+ as the charge carrier. If pyruvate selectively interferes with Ca 2+ -dependent rapid inactivation, the Na + current should be unaffected. Figure 4D shows that this was the case; hyperpolarization to 2120mV evoked a noninactivating current that was unaffected by 5 mM pyruvate. Hence pyruvate does not affect channel function per se; rather it interferes selectively with rapid inactivation. Close inspection of the current-voltage relationship in divalent-free solution revealed a slight change in the outward current ( Figures 4E and 4F ), hinting at the possibility that pyruvate might indeed bind to the channels. We conclude that pyruvate competes with or reduces the efficacy of Ca 2+ at the channel. If the mechanism entails competitive inhibition, then our assessment of the pyruvate effects is likely a significant underestimate of its true impact because, by necessity, we record CRAC channels in 10 mM Ca 2+ , favoring Ca 2+ over pyruvate.
Conclusion
We have found that a key metabolic product, pyruvic acid, can impact the activity of CRAC channels, significantly reducing the extent of rapid Ca 2+ -dependent inactivation. This would increase the amount of Ca 2+ that enters the cell and hence results in more sustained Ca 2+ -dependent signaling. Fluctuations in the levels of intracellular pyruvate, as occurs after changes in anaerobic to aerobic metabolism, would therefore provide a novel means for controlling the extent of Ca 2+ influx. This effect of pyruvate is independent of the generation of a range of mitochondrially derived products arising from its metabolism, and it does not involve increased mitochondrial-Ca 2+ buffering or -ATP production and is independent of pyruvate's weak Ca 2+ -binding capacity. Instead, our results suggest that pyruvate interacts with CRAC channels, reducing the ability of intracellular Ca 2+ to evoke rapid inactivation. These effects were manifest at pyruvate concentrations of w1 mM, well within the physiological range. Moreover, the effects of pyruvate were prominent at potentials negative to 260mV, close to the potential seen in mast cells following receptor stimulation (approximately 280mV [14] ). CRAC channels are therefore the first known class of ion channel that can be regulated by an intermediary metabolite, thereby providing an important potential link between energy metabolism and Ca 2+ influx. 
